Video

ARVO LIVE: Insight into cell death with AMD

Ophthalmology Times® talked with Deborah Ferrington, PhD, about her presentation on using human donor tissue to identify the mechanism responsible for the death of the retinal pigment epithelium.

Ophthalmology Times® talked with Deborah Ferrington, PhD, about her presentation on using human donor tissue to identify the mechanism responsible for the death of the retinal pigment epithelium.

Video transcript

Editor’s note: Transcript edited for clarity

Deborah Ferrington, PhD:

Good afternoon. My name is Deborah Ferrington, and I'm the Chief Scientific Officer at Doheny Eye Institute. I'm here at the ARVO meeting in New Orleans. And I gave a talk this morning on the cell death group. And what I talked about was our work using human donor tissue to identify the mechanism responsible for the death of the retinal pigment epithelium.

The group that we looked at were donors that had the complement factor, high-risk allele that is associated with AMD. We compared their results with donors that have the low-risk allele. What we found is that donors with high-risk for AMD, they had lower mitochondrial function and this lower mitochondrial function could be one of the things that tips the balance between a healthy donor's RPE and those that go into age-related macular degeneration.

Related Videos
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.